By intent-to-treat analysis of both dose groups combined (n=57), where patients with missing values are considered virologic failures, the proportion of patients with HIV RNA < 400 copies/ ml at 48 weeks was 65% and the mean increase from baseline CD4 cell count was 94 cells/ mm3.
48. nädalaks oli HIV RNA < 400 koopiat/ ml patsientide osakaal 65% ning keskmine CD4 rakkude arvu tõus oli 94 rakku / mm3.